Clinical trial
N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity
NCT00267384 · Soroka University Medical Center, Other · Completed
Key facts
| NCT number | NCT00267384 |
|---|---|
| Title | N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity |
| Lead sponsor | Soroka University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Drug Induced Nephrotoxicity |
| Intervention type | Drug |
| Interventions | Oral N-Acetylcysteine |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Dec 20, 2005 |
| Last update posted | Jun 20, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: